Clinical Trials Browser

Completed × INDUSTRY × tasquinimod × Clear all

NCT00560482 2015-10-26

Efficacy Study of ABR-215050 to Treat Prostate Cancer

Phase 2 Completed

Neoplasms, Prostatic Neoplasms

NCT01234311 2015-10-21

A Study of Tasquinimod in Men With Metastatic Castrate Resistant Prostate Cancer

Phase 3 Completed

Prostatic Neoplasms